1921
Volume 99, Issue 2
  • ISSN: 0002-9637
  • E-ISSN: 1476-1645

Abstract

Abstract.

A quantifiable, stool-based, () test has potential complementary value to respiratory specimens. Limit of detection (LOD) was determined by spiking control stool. Clinical test performance was evaluated in a cohort with pulmonary tuberculosis (TB) ( = 166) and asymptomatic household TB child contacts ( = 105). Stool-quantitative polymerase chain reaction (qPCR) results were compared with sputum acid-fast bacilli (AFB) microscopy, GeneXpert MTB/RIF (Xpert MTB/RIF), and cultures. In stool-spiking studies, the LOD was 96 colony-forming units/50 mg of stool (95% confidence interval [CI]: 84.8–105.6). Among specimens collected within 72 hours of antituberculosis treatment (ATT) initiation, stool qPCR detected 22 of 23 (95%) of culture-positive cases. Among clinically diagnosed cases that were Xpert MTB/RIF and culture negative, stool qPCR detected an additional 8% (3/37). Among asymptomatic, recently TB-exposed participants, stool PCR detected in two of 105 (1.9%) patients. Two months after ATT, the quantitative burden in femtogram per microliters decreased (Wilcoxon signed-rank < 0.001) and persistent positive stool PCR was associated with treatment failure or drug resistance (relative risk 2.8, CI: 1.2–6.5; = 0.012). Stool-based qPCR is a promising complementary technique to sputum-based diagnosis. It detects and quantifies low levels of stool DNA, thereby supporting adjunct diagnosis and treatment monitoring in pulmonary TB.

Loading

Article metrics loading...

/content/journals/10.4269/ajtmh.18-0004
2018-08-02
2018-08-14
Loading full text...

Full text loading...

/deliver/fulltext/14761645/99/2/tpmd180004.html?itemId=/content/journals/10.4269/ajtmh.18-0004&mimeType=html&fmt=ahah

References

  1. WHO, 2016. Global Tuberculosis Report 2016. Geneva, Switzerland: World Health Organization.
  2. Harries AD, Hargreaves NJ, Kemp J, Jindani A, Enarson DA, Maher D, Salaniponi FM, , 2001. Deaths from tuberculosis in sub-Saharan African countries with a high prevalence of HIV-1. Lancet 357: 15191523.
  3. Harries AD, Nyirenda TE, Banerjee A, Boeree MJ, Salaniponi FM, , 1999. Treatment outcome of patients with smear-negative and smear-positive pulmonary tuberculosis in the National Tuberculosis Control Programme, Malawi. Trans R Soc Trop Med Hyg 93: 443446.
  4. Macpherson P, 2011. Risk factors for mortality in smear-negative tuberculosis suspects: a cohort study in Harare, Zimbabwe. Int J Tuberc Lung Dis 15: 13901396.
  5. Perez-Velez CM, Marais BJ, , 2012. Tuberculosis in children. N Engl J Med 367: 348361.
  6. Gupta RK, Lucas SB, Fielding KL, Lawn SD, , 2015. Prevalence of tuberculosis in post-mortem studies of HIV-infected adults and children in resource-limited settings: a systematic review and meta-analysis. AIDS 29: 19872002.
  7. WHO, 2015. Global Tuberculosis Report. Geneva, Switzerland: World Health Organization.
  8. Small PM, Pai M, , 2010. Tuberculosis diagnosis–time for a game change. N Engl J Med 363: 10701071.
  9. Detjen AK, DiNardo AR, Leyden J, Steingart KR, Menzies D, Schiller I, Dendukuri N, Mandalakas AM, , 2015. Xpert MTB/RIF assay for the diagnosis of pulmonary tuberculosis in children: a systematic review and meta-analysis. Lancet Respir Med 3: 451461.
  10. Aryan E, Makvandi M, Farajzadeh A, Huygen K, Alvandi AH, Gouya MM, Sadrizadeh A, Romano M, , 2013. Clinical value of IS6110-based loop-mediated isothermal amplification for detection of Mycobacterium tuberculosis complex in respiratory specimens. J Infect 66: 487493.
  11. Jeanes C, O’Grady J, , 2016. Diagnosing tuberculosis in the 21st century—dawn of a genomics revolution? Int J Mycobacteriol 5: 384391.
  12. Pholwat S, Stroup S, Foongladda S, Houpt E, , 2013. Digital PCR to detect and quantify heteroresistance in drug resistant Mycobacterium tuberculosis. PLoS One 8: e57238.
  13. Steingart KR, Sohn H, Schiller I, Kloda LA, Boehme CC, Pai M, Dendukuri N, , 2013. Xpert® MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults. Cochrane Database Syst Rev 1: CD009593.
  14. Ulmar D, Ornstein OG, , 1933. Gastric examination in pulmonary tuberculosis with negative sputum: diagnostic importance. JAMA 101: 835836.
  15. Alonso JM, , 2008. Immunity and pathophysiology of respiratory tract infections. Med Mal Infect 38: 433437.
  16. DiNardo AR, Hahn A, Leyden J, Stager C, Baron EJ, Graviss EA, Mandalakas AM, Guy E, , 2015. Use of string test and stool specimens to diagnose pulmonary tuberculosis. Int J Infect Dis 41: 5052.
  17. Wolf H, 2008. Diagnosis of pediatric pulmonary tuberculosis by stool PCR. Am J Trop Med Hyg 79: 893898.
  18. Kokuto H, Sasaki Y, Yoshimatsu S, Mizuno K, Yi L, Mitarai S, , 2015. Detection of Mycobacterium tuberculosis (MTB) in fecal specimens from adults diagnosed with pulmonary tuberculosis using the Xpert MTB/rifampicin test. Open Forum Infect Dis 2: ofv074.
  19. Nicol MP, Spiers K, Workman L, Isaacs W, Munro J, Black F, Zemanay W, Zar HJ, , 2013. Xpert MTB/RIF testing of stool samples for the diagnosis of pulmonary tuberculosis in children. Clin Infect Dis 57: e18e21.
  20. Marcy O, 2016. Performance of Xpert MTB/RIF and alternative specimen collection methods for the diagnosis of tuberculosis in HIV-infected children. Clin Infect Dis 62: 11611168.
  21. Walters E, 2017. Xpert MTB/RIF on stool is useful for the rapid diagnosis of tuberculosis in young children with severe pulmonary disease. Pediatr Infect Dis J 36: 837843.
  22. Taylor N, Gaur RL, Baron EJ, Banaei N, , 2012. Can a simple flotation method lower the limit of detection of Mycobacterium tuberculosis in extrapulmonary samples analyzed by the GeneXpert MTB/RIF assay? J Clin Microbiol 50: 22722276.
  23. Banada PP, Naidoo U, Deshpande S, Karim F, Flynn JL, O’Malley M, Jones M, Nanassy O, Jeena P, Alland D, , 2016. A novel sample processing method for rapid detection of tuberculosis in the stool of pediatric patients using the Xpert MTB/RIF assay. PLoS One 11: e0151980.
  24. Nahid P, 2016. Executive summary: Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice guidelines: treatment of drug-susceptible tuberculosis. Clin Infect Dis 63: 853867.
  25. Detjen AKDA, Leyden J, Steingart KR, Menzies D, Schiller I, Dendukuri N, Mandalakas AM, , 2013. Systematic Review and Meta-Analysis: Xpert MTB/RIF for the Diagnosis of Pulmonary Tuberculosis, Peripheral Lymph Node TB and TB meningitis in Children. WHO Expert Group Meeting on Use of Xpert MTB/RIF in TB control in low and middle-income settings. WHO Expert Meeting, May 20–21, 2013, Vevrier Du-Lac, France.
  26. Malherbe ST, 2016. Persisting positron emission tomography lesion activity and Mycobacterium tuberculosis mRNA after tuberculosis cure. Nat Med 22: 10941100.
  27. Shenai S, 2016. Bacterial loads measured by the Xpert MTB/RIF assay as markers of culture conversion and bacteriological cure in pulmonary TB. PLoS One 11: e0160062.
  28. Barletta F, Vandelannoote K, Collantes J, Evans CA, Arevalo J, Rigouts L, , 2014. Standardization of a TaqMan-based real-time PCR for the detection of Mycobacterium tuberculosis-complex in human sputum. Am J Trop Med Hyg 91: 709714.
  29. Graham SM, 2012. Evaluation of tuberculosis diagnostics in children: 1. Proposed clinical case definitions for classification of intrathoracic tuberculosis disease. Consensus from an expert panel. J Infect Dis 205 (Suppl 2): S199S208.
  30. Mejia R, Vicuna Y, Broncano N, Sandoval C, Vaca M, Chico M, Cooper PJ, Nutman TB, , 2013. A novel, multi-parallel, real-time polymerase chain reaction approach for eight gastrointestinal parasites provides improved diagnostic capabilities to resource-limited at-risk populations. Am J Trop Med Hyg 88: 10411047.
  31. Cepheid, 2015. Xpert MTB/RIF Package Insert. Available at: http://www.cepheid.com/us/mtbrif-pi. Accessed April 27, 2018.
  32. Van Rie A, , 2013. Xpert MTB/RIF: a game changer for the diagnosis of pulmonary tuberculosis in children? Lancet Glob Health 1: e60e61.
  33. Desjardin LE, 1999. Measurement of sputum Mycobacterium tuberculosis messenger RNA as a surrogate for response to chemotherapy. Am J Respir Crit Care Med 160: 203210.
  34. Foley JA, Andosca JB, , 1943. The value of the examination of gastric contents for tubercle bacilli. Ann Intern Med 19: 629633.
  35. Walters E, Gie RP, Hesseling AC, Friedrich SO, Diacon AH, Gie RP, , 2012. Rapid diagnosis of pediatric intrathoracic tuberculosis from stool samples using the Xpert MTB/RIF Assay: a pilot study. Pediatr Infect Dis J 31: 1316.
  36. Lok KH, Benjamin WH, Jr. Kimerling ME, Pruitt V, Lathan M, Razeq J, Hooper N, Cronin W, Dunlap NE, , 2002. Molecular differentiation of Mycobacterium tuberculosis strains without IS6110 insertions. Emerg Infect Dis 8: 13101313.
http://instance.metastore.ingenta.com/content/journals/10.4269/ajtmh.18-0004
Loading
/content/journals/10.4269/ajtmh.18-0004
Loading

Data & Media loading...

Supplementary Data

Supplemental Figure and table

  • Received : 03 Jan 2018
  • Accepted : 04 Mar 2018

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error